Table 2 Levels of serum HBV RNA at baseline and on-treatment: relationship to response at 24 weeks posttreatment
HBV RNA (copies/mL) | Total No. of patients | No. of patients with HBeAg seroconversion | Percentage of patients with HBeAg seroconversion | |
|---|---|---|---|---|
Baseline | ≦ 200,000 | 25 | 14 | 56.0% |
> 200,000 | 36 | 8 | 22.2% | |
Week 12 | ≦ 3000 | 20 | 15 | 75.0% |
> 3000 | 41 | 7 | 17.1% | |
Week 24 | ≦ 1000 | 17 | 12 | 70.6% |
>  1000 | 44 | 10 | 22.7% |